NCT02818686 - TD-1473 for Active Ulcerative Colitis (UC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 3, 2016

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions

Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe

Interventions

DRUG

TD-1473

DRUG

Placebo

Trial Locations (8)

Theravance Biopharma Investigational Site, Hermitage

Theravance Biopharma Investigational Site, Bucharest

Theravance Biopharma Investigational Site, Monroe

Theravance Biopharma Investigational Site, Houston

Theravance Biopharma Investigational Site, San Antonio

Theravance Biopharma Investigational Site, Scottsdale

Theravance Biopharma Investigational Site, Tbilisi

Theravance Biopharma Investigational Site, Chisinau